Cargando…

Recombinant Human Bone Morphogenetic Protein-2 in Posterolateral Spinal Fusion: What's the Right Dose?

STUDY DESIGN: Single center retrospective cohort analysis. PURPOSE: The goal was to evaluate the influence of varying amount of recombinant human bone morphogenetic protein 2 (rhBMP-2) per level on fusion rates and complications in posterolateral spinal fusions. OVERVIEW OF LITERATURE: rhBMP-2 has b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann, Martin Franz, Jones, Clifford Barry, Sietsema, Debra Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Spine Surgery 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917763/ https://www.ncbi.nlm.nih.gov/pubmed/27340524 http://dx.doi.org/10.4184/asj.2016.10.3.457

Ejemplares similares

Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly
por: Hoffmann, Martin F, et al.
Publicado: (2013)

Comparison of Silicate-Substituted Calcium Phosphate (Actifuse) with Recombinant Human Bone Morphogenetic Protein-2 (Infuse) in Posterolateral Instrumented Lumbar Fusion
por: Licina, Paul, et al.
Publicado: (2015)

Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Multilevel Posterolateral Lumbar Fusion in a Prospective, Randomized, Controlled Trial
por: Choi, Ho Yong, et al.
Publicado: (2022)

Interbody fusion in degenerative lumbar spinal stenosis with additional posterolateral fusion using Escherichia coli-derived bone morphogenetic protein-2: A Pilot study
por: Choi, Sung Hoon, et al.
Publicado: (2020)

Ovariectomy-Induced Osteoporosis Does Not Impact Fusion Rates in a Recombinant Human Bone Morphogenetic Protein-2–Dependent Rat Posterolateral Arthrodesis Model
por: Ghodasra, Jason H., et al.
Publicado: (2015)

Bone Marrow Mesenchymal Stem Cells Expressing Baculovirus-Engineered Bone Morphogenetic Protein-7 Enhance Rabbit Posterolateral Fusion
por: Liao, Jen-Chung
Publicado: (2016)

Comparing cellular bone matrices for posterolateral spinal fusion in a rat model
por: Lin, Cliff, et al.
Publicado: (2020)

Complications of Anterior Cervical Fusion using a Low-dose Recombinant Human Bone Morphogenetic Protein-2
por: Kukreja, Sunil, et al.
Publicado: (2015)

Current Trends in Recombinant Human Bone Morphogenetic Protein 2 (rhBMP2) Usage for Spinal Fusion Surgery
por: Patel, Harshadkumar A., et al.
Publicado: (2023)

Lumbar Spine Fusion Rates With Local Bone in Posterolateral and Combined Posterolateral and Interbody Approaches
por: Park, Daniel K., et al.
Publicado: (2019)

Epidermal growth factor enhances spinal fusion: Posterolateral lumbar fusion model on rats
por: Çetin, Engin, et al.
Publicado: (2019)

Bone morphogenetic protein-2-mediated pain and inflammation in a rat model of posterolateral arthrodesis
por: Mitchell, Kendall, et al.
Publicado: (2016)

Fusion Rates of Lateral Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2
por: Nourian, Ardalan A., et al.
Publicado: (2018)

The fusion rate of demineralized bone matrix compared with autogenous iliac bone graft for long multi-segment posterolateral spinal fusion
por: Fu, Tsai-Sheng, et al.
Publicado: (2016)

Increasing Fusion Rate Between 1 and 2 Years After Instrumented Posterolateral Spinal Fusion and the Role of Bone Grafting
por: Lehr, A. Mechteld, et al.
Publicado: (2020)

Does plate type influence the clinical outcomes and implant removal in midclavicular fractures fixed with 2.7-mm anteroinferior plates? A retrospective cohort study
por: Gilde, Alex K, et al.
Publicado: (2014)

Functional outcomes of operative fixation of clavicle fractures in patients with floating shoulder girdle injuries
por: Gilde, Alex K., et al.
Publicado: (2015)

Outcome of intramedullary nailing treatment for intertrochanteric femoral fractures
por: Hoffmann, Martin F., et al.
Publicado: (2019)

Minimally Invasive Lumbar Decompression and Removal of Symptomatic Heterotopic Bone Formation After Spinal Fusion with Recombinant Human Bone Morphogenetic Protein-2
por: Roberti, Fabio, et al.
Publicado: (2020)

Effect of Bone Morphogenetic Protein-2 (BMP-2)/Hydroxyapatite/In Situ-Formed Hyaluronan Hydrogel Composites on Bone Formation in a Murine Model of Posterolateral Lumbar Fusion
por: Kuroda, Akiyoshi, et al.
Publicado: (2022)

Experimental posterolateral spinal fusion with beta tricalcium phosphate ceramic and bone marrow aspirate composite graft
por: Gupta, Ankit, et al.
Publicado: (2010)

Fusion and Healing Prediction in Posterolateral Spinal Fusion Using (18)F-Sodium Fluoride-PET/CT
por: Constantinescu, Caius M., et al.
Publicado: (2020)

Commentary: Bone morphogenetic protein's contribution to pulmonary artery hypertension: Should this raise concern for patients undergoing spinal fusions with bone morphogenetic protein?
por: Epstein, Nancy E.
Publicado: (2014)

Trends and Cost of Posterior Cervical Fusions With and Without Recombinant Human Bone Morphogenetic Protein-2 in the US Medicare Population
por: Myhre, Sue Lynn, et al.
Publicado: (2017)

Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis
por: Roh, Jeffrey S, et al.
Publicado: (2013)

In the era of recombinant BMP, does additional anterior stabilization add value to a posterolateral fusion?
por: Dhoke, Priyesh, et al.
Publicado: (2012)

Multilevel instrumented posterolateral lumbar spine fusion with an allogeneic cellular bone graft
por: Hall, John F., et al.
Publicado: (2019)

Anatomy of the posterolateral spinal epidural ligaments
por: Santos, Jaime L. Martinez, et al.
Publicado: (2021)

Clinical outcomes of locked plating of distal femoral fractures in a retrospective cohort
por: Hoffmann, Martin F, et al.
Publicado: (2013)

Recombinant human bone morphogenetic protein 2 labeled use in spinal surgery and sexual dysfunction
por: Rakovac, Marija, et al.
Publicado: (2011)

Quality-of-Life Outcomes following Thoracolumbar and Lumbar Fusion with and without the Use of Recombinant Human Bone Morphogenetic Protein-2: Does Recombinant Human Bone Morphogenetic Protein-2 Make a Difference?
por: Lubelski, Daniel, et al.
Publicado: (2014)

Effectiveness and safety of recombinant human bone morphogenetic protein-2 for adults with lumbar spine pseudarthrosis following spinal fusion surgery: A systematic review
por: Bodalia, P. N., et al.
Publicado: (2016)

Combined magnetic fields provide robust coverage for interbody and posterolateral lumbar spinal fusion sites
por: Stippick, Timothy Wade, et al.
Publicado: (2015)

Biphasic calcium phosphate with submicron surface topography in an Ovine model of instrumented posterolateral spinal fusion
por: van Dijk, Lukas A., et al.
Publicado: (2018)

The effect of local steroid application on bony fusion in a rat posterolateral spinal arthrodesis model
por: Kannan, Abhishek, et al.
Publicado: (2021)

Evaluation of hydroxyapatite and beta-tricalcium phosphate mixed with bone marrow aspirate as a bone graft substitute for posterolateral spinal fusion
por: Bansal, Sanjay, et al.
Publicado: (2009)

Clinical and Radiological Comparison of Posterolateral Fusion and Posterior Interbody Fusion Techniques for Multilevel Lumbar Spinal Stabilization In Manual Workers
por: Aygün, Hayati, et al.
Publicado: (2014)

A Computed Tomography Analysis of the Success of Spinal Fusion Using Ultra-Low Dose (0.7 mg per Facet) of Recombinant Human Bone Morphogenetic Protein 2 in Multilevel Adult Degenerative Spinal Deformity Surgery
por: Liu, Gabriel, et al.
Publicado: (2018)

Posterolateral decompression, bone graft fusion, posterior instrumentation, and local continuous chemotherapy in the surgical treatment of thoracic spinal tuberculosis
por: Yin, Xin Hua, et al.
Publicado: (2018)

Trends of Posterior Long Segment Fusion with and without Recombinant Human Bone Morphogenetic Protein 2 in Patients with Scoliosis
por: Ruofeng, Yin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3g567ul9ejd0ahfjn6qalebggo